Jan 26, 2016 by Brian FeroldiWhy MannKind Corporation's Stock Is Up TodayA few details emerge about the company's new licensing partner, putting the market in a good mood.
Jan 26, 2016 by Brian Feroldi4 Things to Watch For When Skyworks Solutions Inc. ReportsFrom margins to new design wins, here are the areas investors should pay attention to.
Jan 25, 2016 by Brian Feroldi3 Reasons to Be Bearish on CVS HealthHere are three possible reasons that 2016 might not be all that great for the pharmacy giant.
Jan 25, 2016 by Brian FeroldiWhy Zafgen Inc's Stock Is in the Red TodayShares took a nose dive on Monday after an investment firm published a short report on the company.
Jan 24, 2016 by Brian Feroldi, Daniel Miller, and Matt DiLalloThe 1 Thing I Wish Someone Had Told Me When I First Started Investing Are you new to investing? Here's the advice that our contributors wish they had received when they first got started.
Jan 23, 2016 by Brian FeroldiLast Week's Best Healthcare ETFHealthcare stocks bounced back after a rough start to the year, and this top healthcare ETF lead the pack this week.
Jan 22, 2016 by Brian FeroldiWhy ResMed Inc's Stock Is Up Big TodayInvestors cheered a better than expected earnings report.
Jan 21, 2016 by Brian FeroldiRegeneron Pharmaceuticals Inc. Stock: Bargain or Rip-Off?After a monstrous 10-year run, Regeneron Pharmaceuticals shares are trading for more than $400 each. Is that price a bargain or a rip-off?
Jan 21, 2016 by Brian FeroldiMannKind Corporation Lands a New Deal -- Were Investors Right to Cheer?Shares jumped after news broke that MannKind has found a new partner to help it develop new products. Does this news bring clarity to the company's immediate future, or is it just smoke and mirrors?
Jan 21, 2016 by Brian FeroldiWhat to Expect From CVS Health Corporation in 20162015 was a big year for the nation's largest pharmacy chain. Will 2016 be bigger still?
Jan 20, 2016 by Brian FeroldiChimerix Inc. Is Roaring Higher Again -- Here's WhyAnalysts and investors continue to warm up to the company's shares after their December implosion.
Jan 19, 2016 by Brian FeroldiWhy Chimerix Inc. Is Up Big TodayShares are recovering today from their massive sell-off, but the company's near-term future remains a mystery.
Jan 17, 2016 by Brian FeroldiThe Best Healthcare ETF of the WeekIt was another rough week for healthcare ETFs, but this fund held up better than the rest.
Jan 15, 2016 by Brian FeroldiWhy Ultragenyx Pharmaceuticals Skyrocketed in 2015A slew of positive clinical data sends shares higher.
Jan 15, 2016 by Brian FeroldiCan Twitter Save MannKind Corporation?MannKind has plans to use social media to help grow script volume for its inhaled insulin.
Jan 14, 2016 by Brian FeroldiMannKind Corporation Is Moving Higher Again -- Here's WhyA presentation at the JP Morgan Healthcare Conference gave its investors a reason to cheer.
Jan 14, 2016 by Brian FeroldiWhy Neurocrine Biosciences Inc.'s Stock Skyrocketed 147% Higher in 2015Clinical progress on its late-stage pipeline has investors feeling bullish.
Jan 14, 2016 by Brian FeroldiZogenix, Inc Gained 29% in 2015 -- Here's WhySolid clinical progress mixed with a few cash infusions has investors feeling bullish.
Jan 14, 2016 by Brian FeroldiWhy Intra-Cellular Therapies Inc. Stock Rocketed 206% Higher In 2015Positive clinical results from a compound with massive potential sends shares screaming higher.
Jan 14, 2016 by Brian FeroldiWhy Keryx Biopharmaceuticals Dropped 64% in 2015It was an awful year for the small-cap biopharma, but things could be looking up in 2016.
